204 related articles for article (PubMed ID: 10648727)
1. Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine.
Boye SM; Rompré PP
J Neurosci; 2000 Feb; 20(3):1229-39. PubMed ID: 10648727
[TBL] [Abstract][Full Text] [Related]
2. Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward.
Benaliouad F; Kapur S; Rompré PP
Neuropsychopharmacology; 2007 Mar; 32(3):551-61. PubMed ID: 16794561
[TBL] [Abstract][Full Text] [Related]
3. Behavioral patterns related to dopamine neurotransmission: effect of acute and chronic antipsychotic drugs.
Ungerstedt U; Ljungberg T
Adv Biochem Psychopharmacol; 1977; 16():193-9. PubMed ID: 18882
[No Abstract] [Full Text] [Related]
4. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
Bruggeman R; Westerink BH; Timmerman W
Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
Ikeda H; Adachi K; Hasegawa M; Sato M; Hirose N; Koshikawa N; Cools AR
J Neural Transm (Vienna); 1999; 106(11-12):1205-16. PubMed ID: 10651114
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons.
Hollerman JR; Abercrombie ED; Grace AA
Neuroscience; 1992; 47(3):589-601. PubMed ID: 1584410
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC.
Baviera M; Invernizzi RW; Carli M
Psychopharmacology (Berl); 2008 Feb; 196(2):269-80. PubMed ID: 17940750
[TBL] [Abstract][Full Text] [Related]
9. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
Zhao C; Li M
Pharmacol Biochem Behav; 2009 Oct; 93(4):433-42. PubMed ID: 19539643
[TBL] [Abstract][Full Text] [Related]
10. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Li M; Sun T; Zhang C; Hu G
Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
[TBL] [Abstract][Full Text] [Related]
11. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats.
Frussa-Filho R; Abílio VC; Bergamo M; Palermo-Neto J
J Pharm Pharmacol; 1997 Apr; 49(4):412-5. PubMed ID: 9232539
[TBL] [Abstract][Full Text] [Related]
12. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine.
Zhang M; Ballard ME; Unger LV; Haupt A; Gross G; Decker MW; Drescher KU; Rueter LE
Behav Brain Res; 2007 Aug; 182(1):1-11. PubMed ID: 17570538
[TBL] [Abstract][Full Text] [Related]
13. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
14. Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens.
Onn SP; Grace AA
J Neurosci; 1995 Nov; 15(11):7024-36. PubMed ID: 7472458
[TBL] [Abstract][Full Text] [Related]
15. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
16. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
Wachtel SR; White FJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
[TBL] [Abstract][Full Text] [Related]
18. Seroquel: electrophysiological profile of a potential atypical antipsychotic.
Goldstein JM; Litwin LC; Sutton EB; Malick JB
Psychopharmacology (Berl); 1993; 112(2-3):293-8. PubMed ID: 7871033
[TBL] [Abstract][Full Text] [Related]
19. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of typical and atypical anti-psychotic drugs on sensitized dopamine receptors: sub-chronic low dose Olanzapine exposure reverses sensitization but a similar regimen of low dose haloperidol potentiates sensitization effects.
Dias FR; de Mello Bastos JM; de Fátima Dos Santos Sampaio M; Carey RJ; Carrera MP
Psychopharmacology (Berl); 2013 Dec; 230(4):579-88. PubMed ID: 23846543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
